Efficacy and safety of human soluble thrombomodulin (ART-123) for treatment of patients in France with sepsis-associated coagulopathy: post hoc analysis of SCARLET

Abstract Background The phase 3 multinational SCARLET study evaluated the efficacy and safety of a recombinant human soluble thrombomodulin (ART-123) for treatment of sepsis-associated coagulopathy (SAC), which correlates with increased mortality risk in patients with sepsis. Although no significant...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Bruno François, Maud Fiancette, Julie Helms, Emmanuelle Mercier, Jean-Baptiste Lascarrou, Toshihiko Kayanoki, Kosuke Tanaka, David Fineberg, Jean-Louis Vincent, Xavier Wittebole
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2021-03-01
סדרה:	Annals of Intensive Care
נושאים:	Sepsis Sepsis-associated coagulopathy Thrombomodulin ART-123 Heparin France
גישה מקוונת:	https://doi.org/10.1186/s13613-021-00842-4
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!